600186.SS SHH
Lotus Health Group Company
1W: -11.4%
1M: -0.9%
3M: -6.5%
YTD: +90.0%
1Y: +85.7%
3Y: +285.9%
5Y: +332.4%
¥11.46 ($1.71)
-0.11 (-0.95%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$2.6B
+26.0% ▲
5Y CAGR: +9.2%
Gross Profit
$669M
+86.1% ▲
5Y CAGR: +31.4%
Operating Income
$278M
+40.2% ▲
5Y CAGR: +49.3%
Net Income
$203M
+55.9% ▲
5Y CAGR: +24.0%
EPS (Diluted)
$0.12
+71.4% ▲
5Y CAGR: +19.0%
EBITDA
$377M
+148.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $1.7B | $1.8B | $1.7B | $2.1B | $2.6B |
| YoY Growth | -2.8% | +9.7% | -6.8% | +24.2% | +26.0% |
| Cost of Revenue | $1.4B | $1.6B | $1.5B | $1.7B | $2.0B |
| Gross Profit | $289M | $223M | $237M | $360M | $669M |
| Gross Margin | 17.5% | 12.3% | 14.0% | 17.1% | 25.3% |
| R&D Expenses | $18M | $22M | $22M | $29M | $41M |
| SG&A Expenses | $151M | $128M | $132M | $181M | $299M |
| Operating Expenses | $185M | $166M | $155M | $161M | $391M |
| Operating Income | $104M | $57M | $82M | $199M | $278M |
| Operating Margin | 6.3% | 3.1% | 4.9% | 9.5% | 10.5% |
| Interest Expense | $22M | $20M | $8M | $1M | $33M |
| Income Before Tax | $104M | $54M | $60M | $171M | $278M |
| Tax Expense | $27M | $11M | $13M | $40M | $78M |
| Net Income | $74M | $44M | $46M | $130M | $203M |
| Net Margin | 4.5% | 2.4% | 2.7% | 6.2% | 7.7% |
| EPS (Diluted) | $0.05 | $0.03 | $0.03 | $0.07 | $0.12 |
| EBITDA | $125M | $77M | $88M | $152M | $377M |
| Shares Outstanding | 1.38B | 1.48B | 1.78B | 1.86B | 1.69B |